| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
42 |
| issn |
1555-175X |
| pageRange |
31-42 |
| publicationName |
Core Evidence |
| startingPage |
31 |
| bibliographicCitation |
Lombo B, Díez JG. Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes. Core Evid. 2011;6():31–42. PMID: 21468241; PMCID: PMC3065559. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6893ba508cf76db2858caf6f6b0208ea
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdf2b2ca2556d65b72a0a404ea24234f |
| date |
201103 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3065559
https://doi.org/10.2147/ce.s9510
https://pubmed.ncbi.nlm.nih.gov/21468241 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1555-175X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37594 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f74135abcce785031995f1a87552cf78
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871419 |